IVI RMA Global and other shareholders have sold their stake in IVI Middle East to Gulf Capital
Founded in 2015 by IVI (now IVIRMA), Suresh Soni, Dr Human Fatemi, IVI Middle East emerged as the leading IVF provider in the Middle East market. The company has two full-service clinics in Abu Dhabi and Muscat along with one outpatient clinic in the Dubai. IVI Middle East is the largest global player in the Gulf region offering world-class facilities and clinical protocols comparable to the highest global success rates. The company is positioned to continue to deliver accelerated growth in a market that is growing at 10%+ every year.
Since its formation, IVI Middle East has delivered significantly better medical outcomes whilst ensuring the safety of patients coupled with the highest ethical standards. IVI Middle East offers personalized treatment and advanced treatment methodologies in IVF. The research-driven approach to treatment methodology drives the higher success rates.
IVI Middle East has an exceptional infrastructure backed by ESHRE trained doctors. The company’s embryologists working in these laboratories are extensively trained, providing them exposure to global best practices in IVF.
Suresh Soni, CEO of IVI Middle East, commented on the transaction, “In Gulf Capital we have found a highly reputable and financially-strong partner to help us realize the further development of our company. With Gulf Capital’s support, we want to continue deepening our presence in the Gulf region and to grow this into a global platform.”
Gaurav Marathe, head Lincoln’s Healthcare Group in India and CEO India, commented, “We are delighted to have advised the shareholders of IVI Middle East on the sale to Gulf Capital. We engaged with the management team at IVI Middle East well ahead of the sale process which allowed us a in depth understanding of business and the IVF opportunity in the Gulf region. IVI Middle East is a unique asset operated by a distinguished management team and is rightly positioned to continue on its journey of extraordinary growth.”
Lincoln International acted as the exclusive M&A advisor to the shareholder consortium of IVI Middle East, preparing and managing a competitive M&A process, securing not only a very attractive economic outcome for the sellers but also identifying an ideal partner for management to implement its long-term vision for IVI Middle East.
Lincoln’s vast knowledge and global experience of the IVF sector proved vital in bringing all the stakeholders together to conclude this transaction. Lincoln leadership played a pivotal role in negotiating the definitive documents, constantly building consensus within shareholder groups with his problem-solving approach.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce that HVR Software, a portfolio company of Level Equity, has agreed to be sold to Fivetran, a portfolio company of Andreessen Horowitz, General Catalyst and ICONIQ Capital in a cash-and-stock deal valued at $700 million
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International is pleased to have represented the shareholders of Epsilon Global Communications on its sale to KT Corporation and Daishin Private Equity for an enterprise value of $145 million
Lincoln International is pleased to have represented CapMan Buyout in the divestment of Solera Beverage Group to the listed beverage company Royal Unibrew
Lincoln International is pleased to announce that it rendered a fairness opinion in connection with this transaction
Lincoln International is pleased to announce that Hg has agreed to make a strategic investment in HHAeXchange
Lincoln International is pleased to announce that Sumeru Equity Partners has sold Azuga to Bridgestone Americas, Inc.
Lincoln International is pleased to announce that it has advised Corndel, a portfolio company of THI Investments, on its recapitalization